Bayer (BAYRY.PK +3.7%) confirms reports that it plans to outsource the entire production of its...

|About: Bayer A.G. ADR (BAYRY)|By:, SA News Editor

Bayer (BAYRY.PK +3.7%) confirms reports that it plans to outsource the entire production of its Betaferon drug for multiple sclerosis, which generated sales of €1.2B ($1.71B) last year, to its biggest German rival, Boehringer Ingelheim.